Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chu

Showing results (441-450 of 495) with videos related to

Pageof 50
Sort By:
British Journal of Haematology|February 13, 2001
A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformationG Jackson, P Taylor, G M Smith, et al.
JAMA Oncology|October 14, 2016
Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical TrialMichael P Chu, J Randolph Hecht, Dennis Slamon, et al.
Nature Medicine|October 24, 2024
Author Correction: Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9Rebekka K Schneider, Monica Schenone, Monica Ventura Ferreira, et al.
Cancer Cell|October 14, 2022
Spatial epitope barcoding reveals clonal tumor patch behaviorsXavier Rovira-Clavé, Alexandros P Drainas, Sizun Jiang, et al.
Nature Medicine|February 16, 2016
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9Rebekka K Schneider, Monica Schenone, Monica Ventura Ferreira, et al.
Leukemia & Lymphoma|May 3, 2022
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCLDeborah A Katz, Joan D Morris, Michael P Chu, et al.
The New England Journal of Medicine|January 8, 2025
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple MyelomaYael C Cohen, Hila Magen, Moshe Gatt, et al.
The Journal of Experimental Medicine|November 7, 2001
Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signalingS J Holland, X C Liao, M K Mendenhall, et al.
BMC Medical Education|July 2, 2025
Achievement emotions in healthcare education: understanding the application of achievement emotions questionnaireFraide A Ganotice, Xiaoai Shen, John Ian Wilzon Tolentino Dizon, et al.
Science (New York, N.Y.)|December 4, 2004
Localization and physical property experiments conducted by Opportunity at Meridiani PlanumR E Arvidson, R C Anderson, P Bartlett, et al.
Pageof 50

Showing results (441-450 of 495) with videos related to

Sort By:
Pageof 50
British Journal of Haematology|February 13, 2001
A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformationG Jackson, P Taylor, G M Smith, et al.
JAMA Oncology|October 14, 2016
Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical TrialMichael P Chu, J Randolph Hecht, Dennis Slamon, et al.
Nature Medicine|October 24, 2024
Author Correction: Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9Rebekka K Schneider, Monica Schenone, Monica Ventura Ferreira, et al.
Cancer Cell|October 14, 2022
Spatial epitope barcoding reveals clonal tumor patch behaviorsXavier Rovira-Clavé, Alexandros P Drainas, Sizun Jiang, et al.
Nature Medicine|February 16, 2016
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9Rebekka K Schneider, Monica Schenone, Monica Ventura Ferreira, et al.
Leukemia & Lymphoma|May 3, 2022
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCLDeborah A Katz, Joan D Morris, Michael P Chu, et al.
The New England Journal of Medicine|January 8, 2025
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple MyelomaYael C Cohen, Hila Magen, Moshe Gatt, et al.
The Journal of Experimental Medicine|November 7, 2001
Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signalingS J Holland, X C Liao, M K Mendenhall, et al.
BMC Medical Education|July 2, 2025
Achievement emotions in healthcare education: understanding the application of achievement emotions questionnaireFraide A Ganotice, Xiaoai Shen, John Ian Wilzon Tolentino Dizon, et al.
Science (New York, N.Y.)|December 4, 2004
Localization and physical property experiments conducted by Opportunity at Meridiani PlanumR E Arvidson, R C Anderson, P Bartlett, et al.
Pageof 50